We’re developing a new modality for medical diagnosis that merges the simplicity and safety of noninvasive liquid biopsies, with the accuracy and clinical utility of tissue-based tests.

Our technology exploits new discoveries about cell-free DNA to power pathbreaking diagnostic
products for oncology, reproductive health, and other important medical indications.